MARKET

EBS

EBS

Emergent Biosolutions Inc
NYSE
6.04
-0.28
-4.43%
Pre Market: 6.33 +0.29 +4.80% 06:52 06/14 EDT
OPEN
6.35
PREV CLOSE
6.32
HIGH
6.48
LOW
6.00
VOLUME
109
TURNOVER
0
52 WEEK HIGH
9.96
52 WEEK LOW
1.420
MARKET CAP
316.51M
P/E (TTM)
-0.5483
1D
5D
1M
3M
1Y
5Y
Emergent Biosolutions Inc: Statement of changes in beneficial ownership of securities
Press release · 2d ago
Weekly Report: what happened at EBS last week (0603-0607)?
Weekly Report · 4d ago
Guru Fundamental Report for EBS
NASDAQ · 06/06 20:04
Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day
National Naloxone Awareness Day is June 6. Emergent BioSolutions Inc. Is highlighting its efforts to combat the opioid epidemic in the U.S. Survey shows a high level of awareness that fentanyl is an opioid and that nalox one can reverse opioid overdoses.
Barchart · 06/06 08:02
12 Health Care Stocks Moving In Wednesday's After-Market Session
Anitra shares increased by 6.5% to $0.18 during Wednesday's after-market session. PACS Group (NYSE:PACS) shares rose 3.95% during the session. Oragenics (AMEX:OGEN) shares moved upwards by 4.24%. Losers include Concord Medical Services and Theriva Biologics.
Benzinga · 06/05 20:31
12 Health Care Stocks Moving In Tuesday's After-Market Session
Concord Medical Services (NYSE:CCM) shares moved upwards by 131.0% to $4.85 during Tuesday's after-market session. The company's market cap stands at $210.6 million. MAIA Biotechnology (AMEX:MAIA) and Emergent BioSolutions (NYSE) also moved upwards.
Benzinga · 06/04 20:31
Weekly Report: what happened at EBS last week (0527-0531)?
Weekly Report · 06/03 09:15
Emergent BioSolutions Shareholders Vote on Strategic Amendments
TipRanks · 05/29 12:49
More
About EBS
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.

Webull offers Emergent Biosolutions Inc stock information, including NYSE: EBS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EBS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EBS stock methods without spending real money on the virtual paper trading platform.